Loading clinical trials...
Loading clinical trials...
Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing - Ascertaining Serial Cancer Patients to Enable New Diagnostic
Conditions
Locations
14
United States
Sarah Cannon
Thousand Oaks, California, United States
Sarah Cannon
Denver, Colorado, United States
Sarah Cannon
Fort Walton Beach, Florida, United States
Sarah Cannon
Ocala, Florida, United States
Sarah Cannon
Pensacola, Florida, United States
Sarah Cannon
Augusta, Georgia, United States
Start Date
November 18, 2019
Primary Completion Date
January 29, 2021
Completion Date
January 29, 2021
Last Updated
June 14, 2024
Lead Sponsor
Exact Sciences Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions